Skip to main content

Internet Explorer 11 (IE11) is not supported. For the best experience please open using Chrome, Firefox, Safari or MS Edge

MHC logo CAPSULE
Medical Devices Pharma Digital Health Cosmetics Food Chemicals
Menu
  • Sectors
  • Medical Devices
  • Pharma
  • Digital Health
  • Cosmetics
  • Food
  • Chemicals
  • Practice Areas
  • Artificial Intelligence
  • Commercial
  • Competition
  • Construction
  • Corporate Governance
  • Cyber Security
  • Data Privacy
  • ESG
  • Healthcare Litigation
  • Intellectual Property
  • Product Liability
  • Real Estate
  • Regulatory
  • Tax
  • Transactional
  • Other
  • Latest
  • People
Search Capsule
Site Search

L a t e s t

  • All
  • News
  • Events
  • Insights
  • Podcasts
  • Videos
  • Clear ✕
  • Clear ✕

15/01/26

Artificial Intelligence Annual Review 2025

News Digital Health

15/01/26

Digital Health Annual Review 2025

News Digital Health

19/12/25

Agreement Reached on EU Pharma Package

Insights Pharma

17/12/25

EU Commission Proposes Reform of the Medical and In Vitro Device Regulations

Insights Medical Devices

03/10/25

NIS2 Considerations for the Life Sciences Sector

Insights Pharma

01/10/25

Update on the EU’s Chemicals Package

Insights Chemicals

01/10/25

TPO Ban in the EU

Insights Cosmetics

01/10/25

Consultation to Simplify EU Rules for Medical Devices

Insights Medical Devices

23/09/25

Clinical Trials and Clinical Investigations in Ireland

Insights Medical Devices

23/09/25

Marketing Authorisations

Insights Pharma

05/08/25

EU General Court Restricts Scope of Dawn Raids

Insights Competition

28/07/25

NIS2 - Ireland’s Risk Management Measures and Cy-Fun

Insights Cyber Security

10/07/25

Product & Consumer Protection Mid-year Review 2025

Insights Regulatory

10/07/25

Digital Health Mid-year Review 2025

Insights Digital Health

10/07/25

Greenwashing: Update on the Green Claims Directive

Insights ESG

24/06/25

Manufacturer Obligations under the New EU Packaging Regulation

Insights Food
Loading
MHC logo CAPSULE
  • Sectors
  • Medical Devices
  • Pharma
  • Digital Health
  • Cosmetics
  • Food
  • Chemicals
  • Other
  • Latest
  • People
  • Practice Areas
  • Artificial Intelligence
  • Commercial
  • Competition
  • Construction
  • Corporate Governance
  • Cyber Security
  • Data Privacy
  • ESG
  • Healthcare Litigation
  • Intellectual Property
  • Product Liability
  • Real Estate
  • Regulatory
  • Tax
  • Transactional
  • Accolades
  • Client Choice
  • Lexology Index
Privacy Policy | Cookie Policy | Disclaimer | Modern Slavery Statement | Accessibility | ©2026 Mason Hayes & Curran LLP